![Kim David Lamon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kim David Lamon
Amministratore Delegato presso Ribapharm, Inc.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Roger D. Loomis | M | - |
Ribapharm, Inc.
![]() Ribapharm, Inc. Pharmaceuticals: MajorHealth Technology Ribapharm, Inc. discovers, develops and markets antiviral and anticancer pharmaceuticals. The company is located in Costa Mesa, CA | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Harry Stylli | M | 62 |
Molecular Insight Pharmaceuticals, Inc.
![]() Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | 6 anni |
Lionel N. Sterling | M | 86 |
Molecular Insight Pharmaceuticals, Inc.
![]() Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | - |
David Stack | M | 72 |
Molecular Insight Pharmaceuticals, Inc.
![]() Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | 4 anni |
John A. Barrett | M | 69 |
Molecular Insight Pharmaceuticals, Inc.
![]() Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | - |
John L. Joyal | M | - |
Molecular Insight Pharmaceuticals, Inc.
![]() Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | - |
James A. Wachholz | M | 70 |
Molecular Insight Pharmaceuticals, Inc.
![]() Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | - |
Priscilla Harlan | F | 71 |
Molecular Insight Pharmaceuticals, Inc.
![]() Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | - |
Joshua D. Hamermesh | M | 51 |
Molecular Insight Pharmaceuticals, Inc.
![]() Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | - |
Robert Gallahue | M | 63 |
Molecular Insight Pharmaceuticals, Inc.
![]() Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | 2 anni |
Nicholas Borys | M | 64 |
Molecular Insight Pharmaceuticals, Inc.
![]() Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | 3 anni |
Danny R. Frank | M | 67 |
Molecular Insight Pharmaceuticals, Inc.
![]() Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | 8 anni |
Norman LaFrance | M | 76 |
Molecular Insight Pharmaceuticals, Inc.
![]() Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | 3 anni |
Brian Abeysekera | M | - |
Molecular Insight Pharmaceuticals, Inc.
![]() Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | - |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 14 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Kim David Lamon
- Contatti personali